Purpose/Objective: According to current evidence radiotherapy (RT) should be delivered to 50% of all cancer patients. In order to use this benchmark value to plan for RT capacity (i.e. linear accelerators and staff) in a given population it is necessary to account also for the proportion of repeat RT courses given after the first radiation treatment. The aim of the study was to determine the patterns of re-treatment for the cohort of patients who received their first RT course in 2009 in a RT department with a stable catchment area of 1.25 million inhabitants. Materials and Methods: From the institutional RT database the following information was retrieved for all new RT patients in 2009: Start date of first treatment course and all subsequent courses, number of fractions and RT technique in each course, cancer diagnosis, age, and intention of the treatment (curative including SBRT and prophylactic RT or palliative). The number of patients receiving their first RT course in 2009 (#first courses) and the total number of reirradiation courses delivered until now (#re-irradiation courses) were determined and the mean number of retreatments was calculated as #re-irradiation courses /#first courses. Results: The median age at first course was 65 y (range 5 mo-95 y). Total #first courses in 2009 were 2666 (1691 curative RT and 875 palliative RT). Breast cancer (46%), prostate cancer (14%) and head and neck cancer (9%) were the three most common diagnoses for patients treated with curative intent in their first course, whereas lung cancer (38%), prostate cancer (10%) and breast cancer (8%) were the most common diagnoses when the intent was palliative. Total #reirradiation courses were 667 resulting in a mean number of re-treatments of 0.25 per patient (664/2666). The proportion of patients re-treated at least once was 18% (475/2666 patients), and three or more courses were given to 133 patients (5%). The maximum number of courses was 8 (one patient). The median time between the first and the second course was 553 and 144 days for patients treated initially with curative intent and palliative intent, respectively. The intent at the second treatment course was palliative for 78% of the patients and curative for 22% of the patients; 29 patients were treated with curative intent in both the first and second course. Breast cancer was the most common diagnosis in that group with 13 patients either treated for a second breast cancer or another cancer. In total 36 of the 2666 patients (1.3%) were later treated with RT for a new cancer diagnosis. Conclusions: With a follow up period of 5 years the reirradiation proportion was found to be 25% and the proportion of patients re-treated was 18%; these numbers are in good agreement with other published series and will be useful for the future planning of radiotherapy services.
Purpose/Objective: During 2009-2011, external peer review clinical audits for breast cancer radiotherapy was carried out at nine radiotherapy centres in Norway. The purpose was to assess compliance with the national radiotherapy guidelines regarding treatment planning for post-operative left sided breast cancer. All radiotherapy departments volunteered to take part in the audits. The audits were organized as a joint project between the Norwegian Breast Cancer Group (NBCG) and the quality assurance group in radiotherapy (KVIST) at the Norwegian Radiation Protection Authority. Materials and Methods: The audit topic was post-operative left sided breast cancer radiotherapy, focusing on indication and radiotherapy treatment planning. The audit standard was the national guidelines for breast cancer treatment (developed by NBCG). A set of audit criteria was developed to evaluate the clinical practice against the national guidelines. A total of 180 treatment files were audited by auditor groups composed of oncologists, medical physicists and RTTs. The audit findings were grouped to analyse the degree of guideline compliance for indication, treatment technique, delineation of treatment volumes and organs at risk, and dose related parameters. Results: Over all, the auditors evaluated the indication, delineation, treatment planning qualitatively to be in accordance to the national guidelines without, or with minor deviance, in 87% of the cases. The treatment planning was in accordance with the guidelines for indication, treatment technique and lung delineation in 98% of the cases, with minor deviations in 2%. For delineation of the clinical target volume (CTV) and the heart, minor deviations were found in 44% of the cases, major deviations in 6%. The dose distribution to the CTV was in accordance with the guidelines in 89% of cases, with minor deviations in 11%. A minimum dose to CTV (breast/breast wall) of at least 95% of prescribed dose (D 98% ≥95%) was attained in 39%, whereas D 98% ≥90% was attained in 93% of the cases. Conclusions: The audits showed that for a large majority of cases, the radiotherapy was planned in accordance to the guideline principles. To define and delineate the target volumes and the heart, and to obtain optimal dose distributions are challenging tasks, for which improvements are still desirable.
